Fierce JPM Week - Virtual Agenda has ended
Back To Schedule
Tuesday, January 18 • 2:50pm - 3:10pm
Improving Translational Medicine by Humanization of Mouse Models: The World’s Largest Pipeline

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

GemPharmatech’s mission is to accelerate innovation and understanding of biological systems to better treat human diseases. We have created over 17,000 mouse models, including Immunodeficient lines (NCG and over 10 derivatives), over 80 humanized models for Immune Checkpoint research, and plan to humanize of 600 new mouse genes in the coming year. We also offer products for research in all areas of biology including neuroscience, metabolism, obesity, cardiovascular and immunology.

avatar for Mark Moore

Mark Moore

CEO, GemPharmatech
Dr. Mark Moore, CEO at GemPharmatech, is a pioneer in the use of genetically modified mice for pharmaceutical and basic research. He has worked in immunology, oncology, animal model construction and gene editing. Before joining GemPharmatech, he was a co-founder and CSO of Deltagen... Read More →

Tuesday January 18, 2022 2:50pm - 3:10pm EST